1174 related articles for article (PubMed ID: 32763266)
1. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis.
Gaul S; Leszczynska A; Alegre F; Kaufmann B; Johnson CD; Adams LA; Wree A; Damm G; Seehofer D; Calvente CJ; Povero D; Kisseleva T; Eguchi A; McGeough MD; Hoffman HM; Pelegrin P; Laufs U; Feldstein AE
J Hepatol; 2021 Jan; 74(1):156-167. PubMed ID: 32763266
[TBL] [Abstract][Full Text] [Related]
2. Antcin A alleviates pyroptosis and inflammatory response in Kupffercells of non-alcoholic fatty liver disease by targeting NLRP3.
Ruan S; Han C; Sheng Y; Wang J; Zhou X; Guan Q; Li W; Zhang C; Yang Y
Int Immunopharmacol; 2021 Nov; 100():108126. PubMed ID: 34492534
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of a Potent and Novel Inhibitor of the NOD-Like Receptor Pyrin Domain-Containing Protein 3 (NLRP3) Inflammasome that Attenuates Development of Nonalcoholic Steatohepatitis and Liver Fibrosis.
Povero D; Lazic M; McBride C; Ambrus-Aikelin G; Stansfield R; Johnson CD; Santini AM; Pranadinata RF; McGeough MD; Stafford JA; Hoffman HM; Feldstein AE; Veal JM; Bain G
J Pharmacol Exp Ther; 2023 Aug; 386(2):242-258. PubMed ID: 37308266
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy.
Yu X; Hao M; Liu Y; Ma X; Lin W; Xu Q; Zhou H; Shao N; Kuang H
Eur J Pharmacol; 2019 Dec; 864():172715. PubMed ID: 31593687
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice.
Wree A; Eguchi A; McGeough MD; Pena CA; Johnson CD; Canbay A; Hoffman HM; Feldstein AE
Hepatology; 2014 Mar; 59(3):898-910. PubMed ID: 23813842
[TBL] [Abstract][Full Text] [Related]
6. Cell-specific Deletion of NLRP3 Inflammasome Identifies Myeloid Cells as Key Drivers of Liver Inflammation and Fibrosis in Murine Steatohepatitis.
Kaufmann B; Kui L; Reca A; Leszczynska A; Kim AD; Booshehri LM; Wree A; Friess H; Hartmann D; Broderick L; Hoffman HM; Feldstein AE
Cell Mol Gastroenterol Hepatol; 2022; 14(4):751-767. PubMed ID: 35787975
[TBL] [Abstract][Full Text] [Related]
7. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC
J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322
[TBL] [Abstract][Full Text] [Related]
8. STING mediates hepatocyte pyroptosis in liver fibrosis by Epigenetically activating the NLRP3 inflammasome.
Xiao Y; Zhao C; Tai Y; Li B; Lan T; Lai E; Dai W; Guo Y; Gan C; Kostallari E; Tang C; Gao J
Redox Biol; 2023 Jun; 62():102691. PubMed ID: 37018971
[TBL] [Abstract][Full Text] [Related]
9. Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation.
Sui YH; Luo WJ; Xu QY; Hua J
World J Gastroenterol; 2016 Feb; 22(8):2533-44. PubMed ID: 26937141
[TBL] [Abstract][Full Text] [Related]
10. Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation.
Liu J; Wang T; He K; Xu M; Gong JP
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8158-8167. PubMed ID: 31599445
[TBL] [Abstract][Full Text] [Related]
11. Baicalin attenuates hepatic injury in non-alcoholic steatohepatitis cell model by suppressing inflammasome-dependent GSDMD-mediated cell pyroptosis.
Shi H; Zhang Y; Xing J; Liu L; Qiao F; Li J; Chen Y
Int Immunopharmacol; 2020 Apr; 81():106195. PubMed ID: 32028242
[TBL] [Abstract][Full Text] [Related]
12. S100A8-Mediated NLRP3 Inflammasome-Dependent Pyroptosis in Macrophages Facilitates Liver Fibrosis Progression.
Liu Y; Kong X; You Y; Xiang L; Zhang Y; Wu R; Zhou L; Duan L
Cells; 2022 Nov; 11(22):. PubMed ID: 36429008
[TBL] [Abstract][Full Text] [Related]
13. The zebrafish NLRP3 inflammasome has functional roles in ASC-dependent interleukin-1β maturation and gasdermin E-mediated pyroptosis.
Li JY; Wang YY; Shao T; Fan DD; Lin AF; Xiang LX; Shao JZ
J Biol Chem; 2020 Jan; 295(4):1120-1141. PubMed ID: 31852739
[TBL] [Abstract][Full Text] [Related]
14. ER stress induces NLRP3 inflammasome activation and hepatocyte death.
Lebeaupin C; Proics E; de Bieville CH; Rousseau D; Bonnafous S; Patouraux S; Adam G; Lavallard VJ; Rovere C; Le Thuc O; Saint-Paul MC; Anty R; Schneck AS; Iannelli A; Gugenheim J; Tran A; Gual P; Bailly-Maitre B
Cell Death Dis; 2015 Sep; 6(9):e1879. PubMed ID: 26355342
[TBL] [Abstract][Full Text] [Related]
15. NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice.
Inzaugarat ME; Johnson CD; Holtmann TM; McGeough MD; Trautwein C; Papouchado BG; Schwabe R; Hoffman HM; Wree A; Feldstein AE
Hepatology; 2019 Feb; 69(2):845-859. PubMed ID: 30180270
[TBL] [Abstract][Full Text] [Related]
16. NLRP3 inflammasome function and pyroptotic cell death in human placental Hofbauer cells.
Abrahams VM; Tang Z; Mor G; Guller S
J Reprod Immunol; 2020 Nov; 142():103214. PubMed ID: 33152658
[TBL] [Abstract][Full Text] [Related]
17. CXCL5 promotes lipotoxicity of hepatocytes through upregulating NLRP3/Caspase-1/IL-1β signaling in Kupffer cells and exacerbates nonalcoholic steatohepatitis in mice.
Qi J; Yan X; Li L; Qiu K; Huang W; Zhou Z
Int Immunopharmacol; 2023 Oct; 123():110752. PubMed ID: 37573690
[TBL] [Abstract][Full Text] [Related]
18. Caspase-1 Inflammasome Activation Mediates Homocysteine-Induced Pyrop-Apoptosis in Endothelial Cells.
Xi H; Zhang Y; Xu Y; Yang WY; Jiang X; Sha X; Cheng X; Wang J; Qin X; Yu J; Ji Y; Yang X; Wang H
Circ Res; 2016 May; 118(10):1525-39. PubMed ID: 27006445
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.
Csak T; Ganz M; Pespisa J; Kodys K; Dolganiuc A; Szabo G
Hepatology; 2011 Jul; 54(1):133-44. PubMed ID: 21488066
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
